Broncho-Vaxom Adult

Country of origin: Switzerland
Pharm-Group: Products that stimulate immune processes

Manufacturers: Om Pharma (Switzerland)
International name: Broncho-Vaxom
Synonyms: Broncho-Vaxom for children
Dosage forms: lyophilized powder 7 mg
Ingredients: Lyophilisate of bacterial lysates.

Indications for use: Prevention of recurrent respiratory tract infections and exacerbations of chronic bronchitis; complex treatment of acute respiratory tract infections.

Contraindications: Hypersensitivity to the components of the drug. Controlled studies have not been conducted in pregnant and lactating women.

Side effects: Manifest in the form of gastrointestinal disorders (nausea, abdominal pain, vomiting), skin reactions (including erythema, itching), respiratory system disorders (cough, shortness of breath), as well as headaches and fatigue.

Interaction: Interaction with other drugs has not yet been established. The drug can be used simultaneously with other drugs used to treat respiratory diseases.

Overdose: There are no data on cases of overdose.

Special instructions: Based on available information, it is not recommended to prescribe to children under 6 months of age, due to the immaturity of their immune system. To avoid overdose in children, do not use the drug from capsules intended for adults. If gastrointestinal, skin or respiratory symptoms persist, you should stop treatment and consult your doctor, as these may be symptoms of allergic reactions.

Literature: Encyclopedia of Medicines 2005